Silibinin protects OTA-mediated TNF-α release from perfused rat livers and isolated rat Kupffer cells

Molecular Nutrition and Food Research

Volumn 53, Issue 4, 2009, Pages 460-466

  Al Anati, Lauy ^a   Essid, Ebtisam ^a   Reinehr, Roland ^b   Petzinger, Ernst ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Kupffer cells; Lipopolysaccharide; Ochratoxin A; Silibinin; TNF

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MYCOTOXIN; OCHRATOXIN; SILIBININ; SILYMARIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; KUPFFER CELL; LIVER; MALE; METABOLISM; PERFUSION; RAT; SECRETION; SILYBUM MARIANUM; WISTAR RAT;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; KUPFFER CELLS; LIPOPOLYSACCHARIDES; LIVER; MALE; MILK THISTLE; MYCOTOXINS; NF-KAPPA B; OCHRATOXINS; PERFUSION; RATS; RATS, WISTAR; SILYMARIN; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 65749099181     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200800110     Document Type: Article

References (43)

1. 4-induced liver cirrhosis by silymarin, Fundam. Clin. Pharmacol. 1989, 3, 183-191.
2. Campos, R., Garrido, A., Guerra, R., Valenzuela, A., Silybin dihemisuccinate protects against glutathione depletion and lipid peroxidation induced by acetaminophen on rat liver, Planta Med. 1989, 55, 417-419.
3. 4 liver damage, J. Appl. Toxicol. 1990, 10, 275-279.
4. Valenzuela, A., Garrido, A., Biochemical bases of the pharmacological action of the flavonoid silymarin and of its structural isomer silibinin, Biol. Res. 1994, 27, 105-112.
5. Dehmlow, C., Erhard, J., de Groot, H., Inhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silibinin, Hepatology 1996, 23, 749-754.
6. Schümann, J., Prockl, J., Kiemer, A.-K., Vollmar, A.-M. et al., Silibinin protects mice from T cell-dependent liver injury, J. Hepatol. 2003, 39, 333-340.
7. Horvath, M.-E., Gonzalez-Cabello, R., Blazovics, A., van der Looij, M. et al., Effect of silibinin and vitamin E on restoration of cellular immune response after partial hepatectomy, J. Ethnopharmacol. 2001, 77, 227-232.
8. Petzinger, E., Ziegler, K., Ochratoxin A from a toxicological perspective, J. Vet. Pharmacol. Ther. 2000, 23, 91-98.
9. JECFA, Ochratoxin A, JECFA 2001, 47; http://www.inchem.org/documents/jecfa/jecmono/v47je04.htm.
10. Weidenbach, A., Petzinger, E., Ochratoxin A: Toxicology of an abundant mycotoxin, Curr. Top. Pharmacol. 2004, 8, 235-250.
11. Ringot, D., Chango, A., Schneider, Y.-J., Larondelle, Y., Toxicokinetics and toxicodynamics of ochratoxin A, an update, Chem. Biol. Interact. 2006, 159, 18-46.
12. Domijan, A.-M., Peraica, M., Vrdoljak, A.-L., Radic, B. et al., The involvement of oxidative stress in ochratoxin A and fumonisin B1 toxicity in rats, Mol. Nutr. Food Res. 2007, 51, 1147-1151.
13. Fuchs, R., Radic, B., Peraica, M., Hult, K., Plestina, R. Enterohepatic circulation of ochratoxin A in rats, Period. Biol. 1988, 90, 39-42.
14. Kanisawa, M., Suzuki, S., Induction of renal and hepatic tumors in mice by ochratoxin A; a mycotoxin, Gann 1987, 69, 599-600.
15. Schlosberg, A., Elkin, N., Malkinson, M., Orgad, U. et al., Severe hepatopathy in geese and broilers associated with ochratoxin in their feed, Mycopathologia 1997, 138, 71-76.
16. Atroshi, F., Biese, I., Saloniemi, H., Ali-Vehmas, T. et al., Significance of apoptosis and its relationship to antioxidants after ochratoxin A administration in mice, J. Pharm. Pharm. Sci. 2000, 3, 281-291.
17. Aydin, G., Ozcelik, N., Cicek, E., Soyoz, M., Histopathologic changes in liver and renal tissues induced by ochratoxin A and melatonin in rats, Hum. Exp. Toxicol. 2003, 22, 383-391.
18. Weidenbach, A., Schuh, K., Failing, K., Petzinger, E., Ochratoxin A induced TNF-a release from the isolated and bloodfree perfused rat liver, Mycotoxin Res. 2000, 16 (A), 189-193.
19. Al-Anati, L., Reinehr, R., Van Rooijen, N., Petzinger, E., In vitro induction of tumor necrosis factor-α by ochratoxin A from rat liver: Role of Kupffer cells, Mycotoxin Res. 2006, 21, 172-175.
20. Al-Anati, L., Katz, N., Petzinger, E., Interference of arachidonic acid and its metabolites with TNF-α release by ochratoxin A from rat liver, Toxicology 2005, 208, 335-346.
21. Eyhorn, S., Schlayer, H.-J., Henninger, H.-P., Dieter, P. et al., Rat hepatic sinusoidal endothelial cells in monolayer culture. Biochemical and ultrastructural characteristics, J. Hepatol. 1988, 6, 23-35.
22. Diehl, A.-M., Cytokine regulation of liver regeneration, in: Fleig, W. E. (Ed.), Normal and Malignant Liver Cell Growth, Kluwer Academic Publisher, Lancaster 1999, pp. 47-55.
23. Al-Anati, L., In Vitro Induction of TNF-alpha by Ochratoxin A, Publisher, VVB Laufersweiler Verlag, 2006.
24. Ferenci, P., Dragosics, B., Dittrich, H., Frank, H. et al., Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver, J. Hepatol. 1989, 9, 105-113.
25. Flora, K., Hahn, M., Rosen, H., Benner, K., Milk thistle (Silybum marianum) for the therapy of liver disease, Am. J. Gastroenterol. 1998, 93, 139-143.
26. Saller, R., Meier, R., Brignoli, R., The use of silymarin in the treatment of liver diseases, Drugs 2001, 61, 2035-2063.
27. Iten, F., Brignoli, R., Meier, R., Reichlin, J., Saller, R., Silymarin bei der Behandlung von Lebererkrankungen (Sily-marin for the treatment of liver diseases), Phytotherapie 2003, 1, 18-24.
28. Letschert, K., Faulstich, H., Keller, D., Keppler, D., Molecular characterization and inhibition of amanitin uptake into human hepatocytes, Toxicol. Sci. 2006, 91, 140-149.
29. Petzinger, E., Ziegler, K., Frimmer, M., Inhibition of 3H demethylphalloin uptake in isolated rat hepatocytes under various experimental conditions, Naunyn-Schmiedeberg's Arch. Pharmacol. 1979, 307, 275-281.
30. Von Schönfeld, J., Weisbrod, B., Müller, M.-K., Silibinin, a plant extract with antioxidant and membrane stabilizing properties, protects exocrine pancreas from cyclosporin A toxicity, Cell. Mol. Life Sci. 1997, 53, 917-920.
31. Wesolowska, O., Lania-Pietrzak, B., Kuzdzal, M., Stanczak, K. et al., Hen influence of silybin on biophysical properties of phospholipid bilayers, Acta Pharmacol. Sin. 2007, 28, 296-306.
32. Bosisio, E., Benelli, C., Pirola, O., Effect of the flavonolignans of Silybum marianum L. on lipid peroxidation in rat liver microsomes and freshly isolated hepatocytes, Pharmacol. Res. 1992, 25, 147-154.
33. Manna, S.-K., Mukhopadhyay, A., Van, N.-T., Aggarwal, B.B., Silymarin suppresses TNF-induced activation of NF-kB, c-Jun N-terminal kinase, and apoptosis, J. Immunol. 1999,163,6800-6809.
34. Schümann, J., Wolf, D., Pahl, A., Brune, K. et al., Importance of Kupffer cells for T cell-dependent liver injury in mice, Am. J. Pathol. 2000, 157, 1671-1683.
35. Min, K., Yoon, W.-K., Kim, S.-K., Kim, B.-H., Immunosuppressive effects of silibinin in experimental autoimmune encephalomyelitis, Arch. Pharm. Res. 2007, 30, 1265-1272.
36. Zi, X., Mukhtar, H., Agarwal, R., Novel cancer chemopreventive effects of a flavonoid antioxidant silymarin: Inhibition of mRNA expression of an endogenous tumor promoter TNFa, Biochem. Biophys. Res. Commun. 1997, 239, 334-339.
37. Tiegs, G., Wolter, M., Wendel, A., Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice, Biochem. Pharmacol. 1989, 38, 627-631.
38. Leist, M., Gantner, F., Bohlinger, I., Germann, P.-G., Tiegs, G. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-α requires transcriptional arrest, J. Immunol. 1994, 153,1778-1788.
39. Koerber, K., Sass, G., Kiemer, A.-K., Vollmar, A.-M., Tiegs, G. n vivo regulation of inducible NO synthase in immunemediated liver injury in mice, Hepatology 2002, 36, 1061-1069.
40. Sass, G., Koerber, K., Bang, R., Guehring, H., Tiegs, G. Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice, J. Clin. Invest. 2001, 107, 439-447.
41. He, Q., Kim, J., Sharma, R.-P., Silymarin protects against liver damage in BALB/c mice exposed to fumonisin B1 despite increasing accumulation of free sphingoid bases, Toxicol. Sci. 2004, 80, 335-342.
42. Preetha, S.-P., Kanniappan, M., Selvakumar, E., Nagaraj, M., Varalakshmi, P., Lupeol ameliorates aflatoxin B1-induced peroxidative hepatic damage in rats, Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2006, 143, 333-339.
43. Zhao, J., Agarwal, R., Tissue distribution of silibinin, the major constituent of silymarin, in mice and its association with enhancement of phase II enzymes: implications in cancer chemoprevention, Carcinogenesis 1999, 20, 2101-2108.